Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 203793
Company: SHANGHAI HENGRUI

Products on ANDA 203793

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
SEVOFLURANE	SEVOFLURANE	100%	LIQUID;INHALATION	Prescription	AN	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 203793

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
11/03/2015	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/08/2023	SUPPL-14	Labeling-Package Insert, Labeling-Container/Carton Labels		Label is not available on this site.
03/08/2023	SUPPL-13	Labeling-Package Insert		Label is not available on this site.
03/08/2023	SUPPL-12	Labeling-Package Insert		Label is not available on this site.
08/11/2020	SUPPL-2	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 203793

SEVOFLURANE

LIQUID;INHALATION; 100%
TE Code = AN

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
SEVOFLURANE	SEVOFLURANE	100%	LIQUID;INHALATION	Prescription	No	AN	075895	BAXTER HLTHCARE
SEVOFLURANE	SEVOFLURANE	100%	LIQUID;INHALATION	Prescription	No	AN	078650	HALOCARBON PRODS
SEVOFLURANE	SEVOFLURANE	100%	LIQUID;INHALATION	Prescription	No	AN	214382	SHANDONG
SEVOFLURANE	SEVOFLURANE	100%	LIQUID;INHALATION	Prescription	No	AN	203793	SHANGHAI HENGRUI
SOJOURN	SEVOFLURANE	100%	LIQUID;INHALATION	Prescription	No	AN	077867	PIRAMAL CRITICAL
ULTANE	SEVOFLURANE	100%	LIQUID;INHALATION	Prescription	Yes	AN	020478	ABBVIE